SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a - 16 OR 15d - 16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April, 2007
SkyePharma PLC
SkyePharma PLC, 105 Piccadilly, London W1J 7NJ England
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______
3 APRIL 2007
SkyePharma PLC - Annual Information Update
In accordance with the requirements of Prospectus Rule 5.2, the following
summarises the information and documents published, or made available to the
public, by SkyePharma between 2 May 2005 and 2 May 2006 The information
referred to in this update was up to date at the time it was published but some
information may now be out of date.
SkyePharma also confirms that it will issue a further Annual Information Update,
within the 20 business days following publication of its annual results, which
will cover the 12-month period immediately preceding such announcement.
1. Announcements via RNS
The following UK regulatory announcements have been made via RNS a Regulatory
Information Service and can be obtained from the London Stock Exchange website
at www.londonstockexchange.com or the Company's website at www.skyepharma.com
Date Announcement
6 May 2005 Additional Listing
9 May 2005 Triglide Approval
23 May 2005 Notification of Shares
24 May 2005 Notification of Shares
31 May 2005 Signed Agreement
1 Jun 2005 Share Purchase Plan
2 Jun 2005 Directors Share Purchase
3 Jun 2005 Director Shareholding
3 Jun 2005 Director Shareholding
6 Jun 2005 Re Convertible Bonds
20 Jun 2005 Approval in Germany
21 Jun 2005 Notification of Shares
28 Jun 2005 Paxil CRTM Returns to US
28 Jun 2005 First Filing for Pulmicort
1 Jul 2005 Share Purchase Plan
18 Jul 2005 US Launch of Triglide
18 Jul 2005 AGM Statement
20 Jul 2005 Notification of Shares
2 Aug 2005 Share Purchase Plan
3 Aug 2005 Notification of Shares
3 Aug 2005 2004 IFRS Figures
31 Aug 2005 Notification of Shares
2 Sep 2005 Results Date & Flutiform Update
7 Sep 2005 Launch of Foradil
8 Sep 2005 Notice of Interims
28 Sep 2005 Rights Issue
28 Sep 2005 Interim Results
30 Sep 2005 Notification of Interests
30 Sep 2005 Notification of Shares
3 Oct 2005 Director/PDMR Shareholding
3 Oct 2005 Holding(s) in Company
5 Oct 2005 Notification of Shares
5 Oct 2005 R&D Day Update
6 Oct 2005 Notification of Shares
6 Oct 2005 Notification of Shares
12 Oct 2005 Filing of Prospectus
17 Oct 2005 Notification of Shares
18 Oct 2005 Notification of Shares
18 Oct 2005 Notification of Shares - Amend
19 Oct 2005 Notification of Shares
21 Oct 2005 Notification of Shares
24 Oct 2005 Notification of Shares
25 Oct 2005 Notification of Shares
1 Nov 2005 Japanese Marketing Agreement
1 Nov 2005 Notification of Shares
3 Nov 2005 Rights Issue
3 Nov 2005 Placement of Rights Issue Rump
3 Nov 2005 Director/PDMR Shareholding
7 Nov 2005 Notification of Shares
10 Nov 2005 Notification of Shares
14 Nov 2005 Strategic Review
14 Nov 2005 Rule 2.10 Announcement
17 Nov 2005 Rule 2.10 Announcement
18 Nov 2005 Rule 2.10 Announcement
30 Nov 2005 Notification of Shares
2 Dec 2005 Holding(s) in Company
2 Dec 2005 Notice of Major Interests
5 Dec 2005 Notification of Shares
8 Dec 2005 Strategic Review Update
13 Dec 2005 Notification of Shares
28 Dec 2005 Share Purchase Plan
11 Jan 2006 Strategic Review
12 Jan 2006 Postponement of R&D Days
13 Jan 2006 Notice of Major Interest
16 Jan 2006 Notice of Major Interest
20 Jan 2006 Resignation of Chairman
20 Jan 2006 Responds to Call for EGM
23 Jan 2006 Holding(s) in Company
26 Jan 2006 Holding(s) in Company
30 Jan 2006 Further re call for EGM
2 Feb 2006 Appointment of New Chairman
3 Feb 2006 Director/PDMR Shareholding
3 Feb 2006 Director/PDMR Shareholding
3 Feb 2006 Director Shareholding
3 Feb 2006 Notification of Shares
6 Feb 2006 Board Appointment
6 Feb 2006 Notification of Shares
6 Feb 2006 Notification of Shares
7 Feb 2006 Response to NAV Syndicate
7 Feb 2006 Notification of Shares
8 Feb 2006 Notification of Shares
9 Feb 2006 Further re Employment Terms
9 Feb 2006 Notification of Shares
9 Feb 2006 Notification of Shares
13 Feb 2006 Former Chairman Retires
13 Feb 2006 Notification of Shares
13 Feb 2006 Notification of Shares
14 Feb 2006 Notification of Shares
15 Feb 2006 Director/PDMR Shareholding
16 Feb 2006 EGM Circular
23 Feb 2006 Notification of Shares
23 Feb 2006 Notification of Shares
27 Feb 2006 EGM Nominee Voting
1 Mar 2006 Share Purchase Plan
2 Mar 2006 Response to NAV
3 Mar 2006 Full Response to NAV
3 Mar 2006 Notification of Shares
3 Mar 2006 Financial Position
6 Mar 2006 Holding(s) in Company
9 Mar 2006 Result of EGM
14 Mar 2006 Agreement over Non-Executives
15 Mar 2006 Notification of Shares
17 Mar 2006 Notification of Shares
27 Mar 2006 Notice of Results
3 Apr 2006 Share Purchase Plan
5 Apr 2006 Board Appointment
19 Apr 2006 Preliminary Results
21 Apr 2006 Propofol Update
24 Apr 2006 Holding(s) in Company
24 Apr 2006 Notification of Interests
24 Apr 2006 Directors Share Awards
26 Apr 2006 Notification of Interests
28 Apr 2006 European Approval of DepoDur
2 May 2006 Notification of Shares
2. Documents filed at Companies House
All of the documents listed below were filed with the Registrar of Companies in
England and Wales on or around the dates indicated. Copies of the documents
filed with the Registrar of Companies can be obtained from Companies House
(www.companieshouse.gov.uk)
Date of Filing Brief Description of document(s) filed
16/05/2005 88(2)R Return Allotment of Shares
28/07/2005 AA Annual Accounts
30/07/2005 RES09 Resolutions
03/08/2005 288b Director Resigned
27/09/2005 288c Directors Particulars Changed
30/01/2006 363 Return made up to 31/12/05
22/02/2006 288b Director resigned
3. Documents published or sent to Shareholders or filed with the UK Listing
Authority viewing facility at:
Financial Services Authority
The North Colonnade
Canary Wharf
London
E14 5HS
Date Document
June 2005 Annual Report and Notice of Meeting
October 2005 Interim Report
October 2005 Rights Issue Prospectus
February 2006 EGM Circular and Notice of Meeting
Copies of the above documents can be obtained from the Company Secretary at:
105 Piccadilly
London
W1J 7NJ
Name of contact and telephone number for queries:
John Murphy
Company Secretary
SkyePharma PLC
Tel: 020 7491 1777
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SkyePharma PLC
By: /s/ John Murphy
Name: John Murphy
Title:
Company Secretary
Date: April 04, 2007